Quick Answer
Anebulo Pharmaceuticals, Inc. reported Total Assets of $12.15 million for fiscal year 2025.
Anebulo Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $12.15M | +198.2% |
| 2024 | $4.07M | -65.1% |
| 2023 | $11.67M | -25.1% |
| 2022 | $15.58M | -28.1% |
| 2021 | $21.65M | +615.0% |
| 2020 | $3.03M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $9.42M | -40.5% | -12.0% |
| September 30, 2025 | $10.70M | +333.6% | -11.9% |
| June 30, 2025 | $12.15M | +198.2% | -13.3% |
| March 31, 2025 | $14.01M | +133.6% | -11.6% |
| December 31, 2024 | $15.84M | +111.2% | +541.9% |
| September 30, 2024 | $2.47M | -72.7% | -39.4% |
| June 30, 2024 | $4.07M | -65.1% | -32.1% |
| March 31, 2024 | $6.00M | -58.5% | -20.1% |
- Anebulo Pharmaceuticals, Inc. showed an increase of +198.2% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Anebulo Pharmaceuticals, Inc.’s total assets has grown by 301.0% (from $3.03 million to $12.15 million).
- The most recent figure is from Anebulo Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: